Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Armstrong

Showing results (31-40 of 215) with videos related to

Pageof 22
Sort By:
Cancer Cell|April 16, 2015
Designed to kill: novel menin-MLL inhibitors target MLL-rearranged leukemiaMichael W M Kühn, Scott A Armstrong
Nature Reviews. Cancer|April 10, 2019
Targeting chromatin complexes in fusion protein-driven malignanciesGerard L Brien, Kimberly Stegmaier, Scott A Armstrong
Current Opinion in Genetics & Development|May 7, 2016
The role of DOT1L in the maintenance of leukemia gene expressionXi Wang, Chun-Wei Chen, Scott A Armstrong
Cold Spring Harbor Perspectives in Medicine|December 18, 2024
Epigenetic TherapiesWallace Bourgeois, Scott A Armstrong, Emily B Heikamp
Annals of the New York Academy of Sciences|October 3, 2009
Transformation from committed progenitor to leukemia stem cellsAndrei V Krivtsov, Zhaohui Feng, Scott A Armstrong
Cold Spring Harbor Perspectives in Medicine|March 1, 2017
Mixed-Lineage Leukemia Fusions and Chromatin in LeukemiaAndrei V Krivtsov, Takayuki Hoshii, Scott A Armstrong
Trends in Biochemical Sciences|April 21, 2021
Histone PTM Crosstalk Stimulates Dot1 Methyltransferase ActivityJevon A Cutler, Florian Perner, Scott A Armstrong
Cancer Cell|June 10, 2008
Linking miRNA regulation to BCR-ABL expression: the next dimensionJörg Faber, Richard I Gregory, Scott A Armstrong
Trends in Immunology|August 8, 2012
Chromatin modifications as therapeutic targets in MLL-rearranged leukemiaAniruddha J Deshpande, James Bradner, Scott A Armstrong
Molecular Cell|November 23, 2015
Drugging Chromatin in Cancer: Recent Advances and Novel ApproachesSheng F Cai, Chun-Wei Chen, Scott A Armstrong
Pageof 22

Showing results (31-40 of 215) with videos related to

Sort By:
Pageof 22
Cancer Cell|April 16, 2015
Designed to kill: novel menin-MLL inhibitors target MLL-rearranged leukemiaMichael W M Kühn, Scott A Armstrong
Nature Reviews. Cancer|April 10, 2019
Targeting chromatin complexes in fusion protein-driven malignanciesGerard L Brien, Kimberly Stegmaier, Scott A Armstrong
Current Opinion in Genetics & Development|May 7, 2016
The role of DOT1L in the maintenance of leukemia gene expressionXi Wang, Chun-Wei Chen, Scott A Armstrong
Cold Spring Harbor Perspectives in Medicine|December 18, 2024
Epigenetic TherapiesWallace Bourgeois, Scott A Armstrong, Emily B Heikamp
Annals of the New York Academy of Sciences|October 3, 2009
Transformation from committed progenitor to leukemia stem cellsAndrei V Krivtsov, Zhaohui Feng, Scott A Armstrong
Cold Spring Harbor Perspectives in Medicine|March 1, 2017
Mixed-Lineage Leukemia Fusions and Chromatin in LeukemiaAndrei V Krivtsov, Takayuki Hoshii, Scott A Armstrong
Trends in Biochemical Sciences|April 21, 2021
Histone PTM Crosstalk Stimulates Dot1 Methyltransferase ActivityJevon A Cutler, Florian Perner, Scott A Armstrong
Cancer Cell|June 10, 2008
Linking miRNA regulation to BCR-ABL expression: the next dimensionJörg Faber, Richard I Gregory, Scott A Armstrong
Trends in Immunology|August 8, 2012
Chromatin modifications as therapeutic targets in MLL-rearranged leukemiaAniruddha J Deshpande, James Bradner, Scott A Armstrong
Molecular Cell|November 23, 2015
Drugging Chromatin in Cancer: Recent Advances and Novel ApproachesSheng F Cai, Chun-Wei Chen, Scott A Armstrong
Pageof 22